Cataract drugs in development, 2023

GlobalData tracks 19 drugs in development for Cataract by 17 companies/universities/institutes. The top development phase for Cataract is preclinical, with 13 drugs in that stage.

Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin

Due to a shortage of a widely used compounded medicine for serious eye diseases, two leading ophthalmologic groups want Medicare contractors to halt practices that

October 13, 2023

J&J to close California R&D facility with plans to open new ‘innovation center’

Johnson & Johnson will close an R&D facility in Brisbane, CA, that it opened less than two years ago to integrate “drug discovery, data science

February 27, 2024

Age-related macular degeneration market expected to reach $27.5bn across 7MM by 2031

Share this article KOLs interviewed by GlobalData have emphasised the need for improvement in several AMD therapies. Credit: GlobalData. The age-related macular degeneration (AMD) market

January 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.